[go: up one dir, main page]

PE38097A1 - NEW CRYSTALLINE FORM OF ACID 7 - ([1a, 5a, 6a] -6-AMINO-3-AZABICICLO [3.1.0] HEX-3-IL) -6-FLUOR-1- (2,4-DIFLUOROFENIL) -1 , 4-DIHIDRO-4-OXO-1,8-NAFTIRIDIN-3-CARBOXILICO ANHYDRO, SALT OF METHANOSULPHONIC ACID - Google Patents

NEW CRYSTALLINE FORM OF ACID 7 - ([1a, 5a, 6a] -6-AMINO-3-AZABICICLO [3.1.0] HEX-3-IL) -6-FLUOR-1- (2,4-DIFLUOROFENIL) -1 , 4-DIHIDRO-4-OXO-1,8-NAFTIRIDIN-3-CARBOXILICO ANHYDRO, SALT OF METHANOSULPHONIC ACID

Info

Publication number
PE38097A1
PE38097A1 PE1996000421A PE00042196A PE38097A1 PE 38097 A1 PE38097 A1 PE 38097A1 PE 1996000421 A PE1996000421 A PE 1996000421A PE 00042196 A PE00042196 A PE 00042196A PE 38097 A1 PE38097 A1 PE 38097A1
Authority
PE
Peru
Prior art keywords
acid
salt
difluorofenil
naftiridin
azabiciclo
Prior art date
Application number
PE1996000421A
Other languages
Spanish (es)
Inventor
Robert L Hendrickson
Lynne A Handanyan
Phillip J Johnson
Thomas A Morris
Timothy Norris
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PE38097A1 publication Critical patent/PE38097A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

CARACTERIZADO PORQUE COMPRENDE OCHO PICOS PRINCIPALES EN SU PATRON DE DIFRACCION DE RAYOS X, CUYAS DISTANCIAS (d) SON: 19,5; 11,5; 9,7; 6,5; 5,9; 4,9; 4,8 Y 3,9. SE REFIERE TAMBIEN AL PROCEDIMIENTO DE PREPARACION DEL ANHIDRATO QUE COMPRENDE EL CALENTAMIENTO DE LA SAL O SU DERIVADO MONOHIDRATO EN PRESENCIA DE UN ALCOHOL O MEZCLA DEL MISMO CON UN DISOLVENTE APROTICO. ESTE AGENTE ANTIBACTERIANO PRESENTA UNA ESTABILIDAD MEJORADA EN SU FORMULACIONCHARACTERIZED BECAUSE IT INCLUDES EIGHT MAIN PEAKS IN ITS X-RAY DIFFACTION PATTERN, WHOSE DISTANCES (d) ARE: 19.5; 11.5; 9.7; 6.5; 5.9; 4.9; 4.8 and 3.9. IT ALSO REFERS TO THE PREPARATION PROCEDURE OF THE ANHYDRATE, WHICH INCLUDES THE HEATING OF THE SALT OR ITS MONOHYDRATE DERIVATIVE IN THE PRESENCE OF AN ALCOHOL OR MIXTURE OF IT WITH A SUITABLE SOLVENT. THIS ANTIBACTERIAL AGENT PRESENTS AN IMPROVED STABILITY IN ITS FORMULATION

PE1996000421A 1995-06-06 1996-06-06 NEW CRYSTALLINE FORM OF ACID 7 - ([1a, 5a, 6a] -6-AMINO-3-AZABICICLO [3.1.0] HEX-3-IL) -6-FLUOR-1- (2,4-DIFLUOROFENIL) -1 , 4-DIHIDRO-4-OXO-1,8-NAFTIRIDIN-3-CARBOXILICO ANHYDRO, SALT OF METHANOSULPHONIC ACID PE38097A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/007211 WO1996039406A1 (en) 1995-06-06 1995-06-06 NOVEL CRYSTAL FORM OF ANHYDROUS 7-([1α, 5α, 6α]-6-AMINO-3-AZABICYCLO[3.1.0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT

Publications (1)

Publication Number Publication Date
PE38097A1 true PE38097A1 (en) 1997-10-10

Family

ID=39431076

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1996000421A PE38097A1 (en) 1995-06-06 1996-06-06 NEW CRYSTALLINE FORM OF ACID 7 - ([1a, 5a, 6a] -6-AMINO-3-AZABICICLO [3.1.0] HEX-3-IL) -6-FLUOR-1- (2,4-DIFLUOROFENIL) -1 , 4-DIHIDRO-4-OXO-1,8-NAFTIRIDIN-3-CARBOXILICO ANHYDRO, SALT OF METHANOSULPHONIC ACID

Country Status (38)

Country Link
US (1) US5763454A (en)
EP (1) EP0789697B1 (en)
JP (1) JP3145715B2 (en)
KR (1) KR100191989B1 (en)
CN (1) CN1055474C (en)
AR (1) AR002753A1 (en)
AU (1) AU703634B2 (en)
BG (1) BG62443B1 (en)
BR (1) BR9602630A (en)
CA (1) CA2223404C (en)
CZ (1) CZ285878B6 (en)
DE (1) DE69503066T2 (en)
DK (1) DK0789697T3 (en)
DZ (1) DZ2046A1 (en)
ES (1) ES2117426T3 (en)
FI (1) FI974441A7 (en)
HR (1) HRP960267B1 (en)
HU (1) HUP9601540A3 (en)
IL (1) IL118488A (en)
IS (1) IS4351A (en)
LV (1) LV11619B (en)
MA (1) MA23892A1 (en)
NO (1) NO305599B1 (en)
NZ (1) NZ286735A (en)
OA (1) OA10293A (en)
PE (1) PE38097A1 (en)
PL (1) PL314604A1 (en)
RU (1) RU2125571C1 (en)
SG (1) SG54339A1 (en)
SI (1) SI9600185A (en)
SK (1) SK280535B6 (en)
TN (1) TNSN96084A1 (en)
TW (2) TW403751B (en)
UA (1) UA44718C2 (en)
UY (1) UY25459A1 (en)
WO (1) WO1996039406A1 (en)
YU (1) YU34596A (en)
ZA (1) ZA964647B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA24500A1 (en) 1997-03-21 1998-10-01 Lg Life Sciences Ltd CARBOXYLIC ACID SALT DERIVATIVE FROM NAPHTHYRIDINE.
US20020032216A1 (en) 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
HN1998000106A (en) 1997-08-01 1999-01-08 Pfizer Prod Inc PARENTERAL COMPOSITIONS OF ALATROFLAXACINO
DE19800214A1 (en) 1998-01-06 1999-07-15 Knoll Ag Process for the preparation of doxazosin mcsylate in a crystal modification referred to as Form A and an intermediate therefor
US7019142B2 (en) * 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
GB9818258D0 (en) * 1998-08-21 1998-10-14 Pfizer Ltd Antifungal compositions
HN1999000141A (en) * 1998-09-03 2000-06-19 Pfizer Prod Inc PROCEDURE FOR PREPARING SALTS OF TROVAFLOXACIN FOR ADDITION OF ACIDS.
GB9820405D0 (en) * 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
ES2164520B1 (en) 1999-03-16 2003-04-01 Medichem Sa "PROCEDURE FOR OBTAINING THE DOXAZOSINE MESYLATE POLYMORPH A"
US6239141B1 (en) 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
US6531603B1 (en) 2001-06-29 2003-03-11 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6573382B2 (en) 2001-06-29 2003-06-03 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6657061B2 (en) 2001-06-29 2003-12-02 Grayson Walker Stowell Polymorphic forms of 6-[4-1(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6660864B2 (en) 2001-06-29 2003-12-09 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6596871B2 (en) 2001-06-29 2003-07-22 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6388080B1 (en) 2001-06-29 2002-05-14 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
KR100517638B1 (en) 2002-04-08 2005-09-28 주식회사 엘지생명과학 New process for preparing acid salts of Gemifloxacin
CN102512364A (en) * 2011-12-30 2012-06-27 天津市嵩锐医药科技有限公司 Alatrofloxacin mesylate medicine composition for injection
TWI608970B (en) * 2013-01-11 2017-12-21 參天製藥股份有限公司 Inner plug and liquid storage container with the plug, tip portion structure of nozzle and liquid storage container with the structure

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
RU2049777C1 (en) * 1989-08-16 1995-12-10 Пфайзер Инк. Azabicyclo-quinolone caroboxylic acids or their pharmaceutically acceptable acid-additive salts and intermediate products for their synthesis
RU2147303C1 (en) * 1994-01-18 2000-04-10 Пфайзер Инк. Intermediates and method of preparing naphthiridone carboxylic acid salts
GB2289674A (en) * 1994-05-23 1995-11-29 Pfizer Antibacterial naphthyridine

Also Published As

Publication number Publication date
BR9602630A (en) 1998-09-08
FI974441L (en) 1997-12-05
NO962321D0 (en) 1996-06-05
BG100639A (en) 1997-02-28
CZ285878B6 (en) 1999-11-17
FI974441A0 (en) 1997-12-05
KR100191989B1 (en) 1999-06-15
HRP960267A2 (en) 1997-08-31
LV11619A (en) 1996-12-20
CZ162596A3 (en) 1998-09-16
SG54339A1 (en) 1998-11-16
MA23892A1 (en) 1996-12-31
LV11619B (en) 1997-04-20
CN1055474C (en) 2000-08-16
JPH10506650A (en) 1998-06-30
HU9601540D0 (en) 1996-07-29
IL118488A (en) 1999-01-26
DE69503066T2 (en) 1998-10-15
HUP9601540A3 (en) 1997-05-28
ES2117426T3 (en) 1998-08-01
NO305599B1 (en) 1999-06-28
AR002753A1 (en) 1998-04-29
RU2125571C1 (en) 1999-01-27
DE69503066D1 (en) 1998-07-23
TNSN96084A1 (en) 2005-03-15
UY25459A1 (en) 1999-11-17
MX9709873A (en) 1998-03-31
JP3145715B2 (en) 2001-03-12
AU5474996A (en) 1996-12-19
WO1996039406A1 (en) 1996-12-12
YU34596A (en) 1999-03-04
ZA964647B (en) 1997-10-22
OA10293A (en) 1997-09-19
PL314604A1 (en) 1996-12-09
NO962321L (en) 1996-12-09
BG62443B1 (en) 1999-11-30
FI974441A7 (en) 1997-12-05
KR970001352A (en) 1997-01-24
TW403751B (en) 2000-09-01
DK0789697T3 (en) 1998-10-19
CA2223404C (en) 2001-01-16
CA2223404A1 (en) 1996-12-12
DZ2046A1 (en) 2002-10-22
CN1148596A (en) 1997-04-30
HRP960267B1 (en) 2000-06-30
AU703634B2 (en) 1999-03-25
IS4351A (en) 1996-12-07
SK71996A3 (en) 1997-03-05
EP0789697B1 (en) 1998-06-17
TW580389B (en) 2004-03-21
SK280535B6 (en) 2000-03-13
US5763454A (en) 1998-06-09
NZ286735A (en) 1998-01-26
SI9600185A (en) 1997-04-30
UA44718C2 (en) 2002-03-15
EP0789697A1 (en) 1997-08-20
HUP9601540A2 (en) 1997-02-28
IL118488A0 (en) 1996-09-12

Similar Documents

Publication Publication Date Title
PE38097A1 (en) NEW CRYSTALLINE FORM OF ACID 7 - ([1a, 5a, 6a] -6-AMINO-3-AZABICICLO [3.1.0] HEX-3-IL) -6-FLUOR-1- (2,4-DIFLUOROFENIL) -1 , 4-DIHIDRO-4-OXO-1,8-NAFTIRIDIN-3-CARBOXILICO ANHYDRO, SALT OF METHANOSULPHONIC ACID
ES2033086T3 (en) A PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION.
ES2193658T3 (en) PROCEDURE FOR THE PREPARATION OF WATERPROOF FORMULATIONS FOR Ophthalmic Use.
DE69211691D1 (en) PHARMACEUTICAL FORMULATION AND PHARMACEUTICAL PROCEDURE
NO993004L (en) New aqueous drug preparations for the production of propellant-free aerosols
ES2123654T3 (en) CARBAPENEMS CONTAINING A PHENYL GROUP SUBSTITUTED WITH CARBOXI, PROCESSES FOR ITS PREPARATION, INTERMEDIATE PRODUCTS AND USE AS ANTIBIOTICS.
ES2185758T3 (en) USE OF ETOXYLATED FATTY ESTERS AS SELF-EMULSIONABLE COMPOUNDS.
MX9402922A (en) IMPROVED PHARMACEUTICALLY ACCEPTABLE COMPOSITIONS.
ES2091019T3 (en) LIPOSOMIC FORMULATIONS OF ITRACONAZOLE.
CO4940430A1 (en) POLYCLIC COMPOUNDS CONTAINING HYDROGENATED STAUROSPORIN WITH CONVENIENT PHARMACOLOGICAL PROPERTIES AND AN INHIBITING EFFECT ON THE GROWTH OF TUMOR CELLS
TNSN87085A1 (en) DERIVATIVES OF 4- (AROYLAMINO) PIPERIDINEBUTANAMIDE, PROCESS FOR THEIR PREPARATION AND THEIR APPLICATION AS ANTIDIARRHOIC
PL328123A1 (en) Derivatives of banzo[c]quinolysine and method of obtaining them
NO980058L (en) Ophthalmic preparations
IT1227362B (en) INDOLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTI-THROMBOTIC DRUGS
CO4750645A1 (en) PREPARATION METHOD OF GRANULES INCORPORATING A MEDICINE FOR PHARMACEUTICAL USE
NO901102D0 (en) PROCEDURE FOR THE PREPARATION OF NEW STEROID DERIVATIVES.
AR008245A1 (en) DERIVATIVES OF ACETIC ACID, USE OF THE SAME IN THE MANUFACTURE OF A THERAPEUTIC AGENT AND PROCESS TO PREPARE SUCH DERIVATIVES
ES2145740T3 (en) GROWTH, PREPARATION AND USE FACTOR COMPOSITIONS.
TR24836A (en) PROCESS FOR THE PREPARATION OF PIRID'S CARBOCYLIC ACID DERIVATIVES
NO905373D0 (en) PROCEDURE FOR THE PREPARATION OF NEW PHOSPHOLIPID DERIVATIVES
ATE12649T1 (en) OPTICALLY ACTIVE DIPEPTIDE, ITS PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
CO4440566A1 (en) NEW CRYSTALLINE FORM OF ACID 7 - ([1 ALPHA, 5 ALPHA, 6ALPHA] - 6-AMINO-3-AZABICICLO [3,1,0] HEX-3-IL) -6-FLUOR-1- (2,4- DIFLUO- ROFENIL) -1,4-DIHIDRO-4-OXO-1,8-NAFTIRIDIN-3-CARBOXILICO AN- HIDRO, SALT OF METHANOSULPHONIC ACID
NO901687D0 (en) PROCEDURE FOR THE PREPARATION OF THIAZETOKINOLIN-3-CARBOXYLIC ACID DERIVATIVES.
IT1146156B (en) ACID DERIVATIVES 2 HYDROXY 5 (1 HYDROXY 2 4 (2 BONE 1 BENZIMIDAZOLINIL) PIPERIDINO) ETHYL BENZOIC AND PROCEDURE FOR THEIR PREPARATION
YU236390A (en) 10,11,12,13-TETRAHYDRO-DESMYCOSIN DERIVATIVES AND PROCESS FOR THEIR OBTAINING

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed